BPC 157: Experimental Peptide Creates Risk for Athletes For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative BPC 157: The Promise and Perils of a Healing Peptide: Apple, Alex: 9798319471673: Amazon.com: Books Thinking about BPC 157? Read this first. 5 things to know before your first reconstitution what it actually does, the standard dose, the rest day mistake most people skip, and the legal status BPC 157 No Proof Required! Office for Science and Society McGill University